Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Taxes (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Current Taxes for 13 consecutive years, with $65000.0 as the latest value for Q1 2025.

  • Quarterly Current Taxes fell 95.64% to $65000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Mar 2025, down 95.64% year-over-year, with the annual reading at $63000.0 for FY2024, 94.92% down from the prior year.
  • Current Taxes for Q1 2025 was $65000.0 at Anika Therapeutics, up from $63000.0 in the prior quarter.
  • The five-year high for Current Taxes was $1.5 million in Q1 2024, with the low at $63000.0 in Q4 2024.
  • Average Current Taxes over 4 years is $646600.0, with a median of $814500.0 recorded in 2022.
  • The sharpest move saw Current Taxes soared 67.6% in 2024, then tumbled 95.64% in 2025.
  • Over 4 years, Current Taxes stood at $810000.0 in 2022, then skyrocketed by 53.09% to $1.2 million in 2023, then plummeted by 94.92% to $63000.0 in 2024, then grew by 3.17% to $65000.0 in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $65000.0, $63000.0, and $82000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.